These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27386883)

  • 1. Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis.
    Jiang H; Wang W; Wang C; Xie X; Hou Y
    Europace; 2017 Mar; 19(3):392-400. PubMed ID: 27386883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Baseline Natriuretic Peptides and Atrial Fibrillation Recurrence After Catheter Ablation.
    Zhang Y; Chen A; Song L; Li M; Chen Y; He B
    Int Heart J; 2016; 57(2):183-9. PubMed ID: 26973277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides as predictors for atrial fibrillation recurrence after catheter ablation: A meta-analysis.
    Yuan Y; Nie B; Gao B; Guo C; Li L
    Medicine (Baltimore); 2023 May; 102(19):e33704. PubMed ID: 37171306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation.
    Miake J; Kato M; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K
    Heart Vessels; 2019 Mar; 34(3):517-526. PubMed ID: 30238353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Yorgun H; Şahiner L; Kaya EB; Çay S; Topaloğlu S; Aras D; Oto A
    Europace; 2015 Dec; 17(12):1807-15. PubMed ID: 25995388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.
    Sasaki N; Okumura Y; Watanabe I; Mano H; Nagashima K; Sonoda K; Kogawa R; Ohkubo K; Nakai T; Hirayama A
    J Interv Card Electrophysiol; 2014 Apr; 39(3):241-9. PubMed ID: 24554250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.
    Badoz M; Serzian G; Favoulet B; Sellal JM; De Chillou C; Hammache N; Laurent G; Mebazaa A; Ecarnot F; Bardonnet K; Seronde MF; Schiele F; Meneveau N
    J Am Heart Assoc; 2021 Jul; 10(13):e020917. PubMed ID: 34187182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults.
    Tang Q; Guo XG; Sun Q; Ma J
    BMC Cardiovasc Disord; 2022 May; 22(1):219. PubMed ID: 35568806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis.
    Boyalla V; Harling L; Snell A; Kralj-Hans I; Barradas-Pires A; Haldar S; Khan HR; Cleland JGF; Athanasiou T; Harding SE; Wong T
    Clin Res Cardiol; 2022 Jun; 111(6):680-691. PubMed ID: 34999932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation.
    Solheim E; Off MK; Hoff PI; De Bortoli A; Schuster P; Ohm OJ; Chen J
    J Interv Card Electrophysiol; 2012 Aug; 34(2):129-36. PubMed ID: 21993599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma norepinephrine level and sick sinus syndrome in patients with lone atrial fibrillation.
    Yoshida K; Kaneshiro T; Ito Y; Kimata A; Koda N; Hiraya D; Baba M; Misaki M; Takeyasu N; Yamaguchi I; Aonuma K
    Heart; 2015 Jul; 101(14):1133-8. PubMed ID: 25968056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation.
    Carballo D; Noble S; Carballo S; Stirnemann J; Muller H; Burri H; Vuilleumier N; Talajic M; Tardif JC; Keller PF; Mach F; Shah D
    J Int Med Res; 2018 Dec; 46(12):5183-5194. PubMed ID: 30178684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of catheter radiofrequency ablation on C-reactive protein, brain natriuretic peptide and echocardiograph in patients with persistent and permanent atrial fibrillation.
    Huang Q; Yuan Y; Qiu C; Zhao Y; Mao Y; Wang R; Wang Q
    Chin Med J (Engl); 2014; 127(4):623-6. PubMed ID: 24534211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
    Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
    J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term changes in heart rate variability after radiofrequency catheter ablation for atrial fibrillation: 1-year follow-up study with irrigation tip catheter.
    Kang KW; Kim TH; Park J; Uhm JS; Joung B; Hwang C; Lee MH; Pak HN
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):693-700. PubMed ID: 24575794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
    Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
    Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of clinical predictors with recurrence of atrial fibrillation after catheter ablation.
    Li A; Chen Y; Wang W; Su L; Ling Z
    Ann Noninvasive Electrocardiol; 2020 Nov; 25(6):e12787. PubMed ID: 32623830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Transforming Growth Factor-β
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):402-409. PubMed ID: 28127812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis.
    Anselmino M; Matta M; D'Ascenzo F; Bunch TJ; Schilling RJ; Hunter RJ; Pappone C; Neumann T; Noelker G; Fiala M; Bertaglia E; Frontera A; Duncan E; Nalliah C; Jais P; Weerasooriya R; Kalman JM; Gaita F
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1011-8. PubMed ID: 25262686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.